AutoHedging

Research · Earnings calendar · IDXX

IDEXX Laboratories, Inc.: results reported 2 November 2026

Written 17 November 2026 from public records. Prices are closing prices to 16 November 2026. Tables are built by the same arithmetic for every company on the calendar; no analyst wrote this page.

What was reported

IDEXX Laboratories, Inc. reported on Monday 2 November 2026. Earnings per share were $3.98. The analysts' average estimate listed by Nasdaq was $3.71, so the result was $0.27 above it. The time of the release was not given, so we do not name one reaction day. The shares closed at $551.21 the day before, $671.64 on the day and $700.65 on 16 Nov.

This page was first written on 17 November 2026, after these results. No preview was written beforehand, so there is nothing of ours to compare the result with. The estimate is a per-share figure collected by Nasdaq's data supplier and may be on a different basis from the company's own headline number.

The chart: above both averages

IDEXX Laboratories, Inc. closed at $700.65 on 16 November 2026. Over the past year the shares are up 2%. That is 9% below the highest close of the year, $766.68 on 25 Nov.

$500 $550 $600 $650 $700 $750 $800 Dec Jan '26 Feb Mar Apr May Jun Jul Aug Sep Oct Nov 1 2 3 4 5 Close50-day average200-day average Volume
IDEXX Laboratories, Inc. daily close, year to 16 November 2026, with 50-day and 200-day averages and daily volume (red bars are down days). Source: Yahoo Finance daily closes; averages and markers are our own arithmetic.
  1. Highest close of the year: $766.68 on 25 Nov.
  2. Lowest close of the year: $504.70 on 11 Sep.
  3. Last crossed above the 50-day average on 15 Oct.
  4. Last crossed above the 200-day average on 2 Nov.
  5. Results on 2 Nov.
Where the price stands, 16 Nov close
MeasureReadingIn plain words
50-day average$565.71The close is 24% above it. It has been on that side since 15 Oct.
200-day average$572.50The close is 22% above it. It has been on that side since 2 Nov.
Distance from the year's high9% belowThe high was $766.68 on 25 Nov.
14-day RSI70Over 70 is the usual line for “overbought”. It describes how fast the price rose, not where it goes next.
Volume0.5 million on 16 Nov1.0 times a normal day (0.5 million, the median of the 60 sessions before).

Who holds IDEXX Laboratories, Inc., and who changed

Managers with $100 million or more in U.S. listed securities report their holdings to the SEC each quarter on Form 13F, within 45 days of the quarter end. At 30 June, 1,306 managers reported 74 million shares, about 95% of the company (91% at 31 March). The reports for 30 September were due on 16 November.

The ten largest reporting holders at 30 June, and what each reported for 30 September. Shares in millions.
HolderWhat kind of account30 June30 SeptemberChangeShare of company
BlackRock, Inc.Mostly index funds8.28.1-0.9%10.3%
Vanguard Capital ManagementMostly index funds5.25.2+0.1%6.5%
Vanguard Portfolio ManagementMostly index funds3.94.0+1.5%5.0%
State StreetMostly index funds3.73.8+0.3%4.8%
Invesco Ltd.Asset manager3.63.4-6.6%4.3%
Geode CapitalMostly index funds2.62.6+2.3%3.3%
Bamco IncAsset manager2.01.8-9.8%2.3%
Morgan StanleyBank: dealer book, asset and wealth arms1.41.4+1.3%1.7%
Bank of New York Mellon CorpAsset manager1.20.9-21.4%1.2%
Arrowstreet Capital, Limited PartnershipAsset manager1.11.4+27.4%1.7%
The 10 read, together32.732.4-1.0%41.2%

What it shows. Cut by 5% or more: Bank of New York Mellon Corp (-21%), Bamco Inc (-10%), Invesco Ltd. (-7%). Added 5% or more: Arrowstreet Capital, Limited Partnership (+27%). These are positions at 30 September. Buying or selling since then is not in any filing yet.

Sources: SEC Form 13F data sets for 30 June (all filers); each holder's own Form 13F for 30 September, read through 13f.info, which republishes the SEC filings. Long share positions only; options and bonds are left out. A bank's filing mixes its trading book with money it manages for clients. Index funds hold a stock at its index weight, so their small changes mostly follow money moving in and out of the funds.

Who has been buying or selling lately

No public record names recent buyers or sellers. Exchanges publish prices and volume, not identities. Each kind of account is disclosed on its own delay.

Kind of accountWhen it is disclosedWhat the record shows now
Officers and directorsForm 4, within two business days of a tradeIn the last 30 days the SEC index for the company lists 6 Form 4 filings and 4 Form 144 notices of a planned sale. A Form 4 can report a sale, a purchase, a grant or shares withheld for tax; we count the filings here and have not read their contents.
Funds, pensions, banksForm 13F, 45 days after each quarter endPositions at 30 September, above. Trading since then first appears in the 31 December reports, due in mid-February 2027.
Holders of 5% or moreSchedule 13G or 13D, after a material change1 schedule filed since 1 October.

What the business numbers show

In the latest reported quarter, to 30 September 2026, revenue was $1.2 billion, up 10% on a year earlier. The quarter before, growth was +10%, so growth was steady. Operating margin was 33.1%, against 32.1% in the same quarter a year earlier.

Quarters as the company reported them to the SEC. A fourth quarter is often missing because companies report it only inside the full year.
Quarter endedRevenueOn a year earlierGross marginOperating marginNet incomeEarnings per share, diluted
30 June 2025$1.1 billion+11%62.6%33.6%$294 million$3.63
30 September 2025$1.1 billion+13%61.8%32.1%$275 million$3.40
31 March 2026$1.1 billion+14%63.4%31.8%$278 million$3.47
30 June 2026$1.2 billion+10%64.0%35.0%$338 million$4.27
30 September 2026$1.2 billion+10%62.9%33.1%$317 million$4.01

Source: the company's reports to the SEC (XBRL company facts, data.sec.gov), CIK 874716. Figures are as filed and are restated when the company restates them. Banks, insurers and some other companies do not report gross or operating profit.